Accelerate your diabetes trials with endocrine expertise
Helping companies bring innovative diabetes and endocrine therapies to market faster.
We specialise in diabetes technology clinical trials, combining scientific rigor with a fast, adaptive approach that keeps pace with rapidly evolving devices.


Years of combined industry experience
Years of combined industry experience
Feasibility and pivotal trials delivered
Feasibility and pivotal trials delivered
Global sponsors supported
Global sponsors supported
Training hours
Training hours

Our Capabilities
We deliver end-to-end diabetes technology trials, enabling sponsors to accelerate R&D programs efficiently.
Diabetes technology feasibility studies
Associate Professor Martin de Bock is considered a global expert in diabetes technologies. Edge Trials brings together technology, healthcare, and trials experience. New Zealand provides a unique opportunity to conduct world class research, within a modern health system, and a clinical trials regulatory framework that facilitates rapid and efficient collaboration. Edge trials has considerable experience in conducting first in human studies.
Pivotal trials for regulatory approval
The team at Edge Trials have experience in conducting trials for regulatory approval (European and FDA pathways). Our study procedures, including infrastructure, insure that clinical trial procedures are of sufficient standard to meet the rigors of external audit.
Our Capabilities
We deliver end-to-end diabetes technology trials, enabling sponsors to accelerate R&D programs efficiently.
Diabetes technology feasibility studies
Associate Professor Martin de Bock is considered a global expert in diabetes technologies. Edge Trials brings together technology, healthcare, and trials experience. New Zealand provides a unique opportunity to conduct world class research, within a modern health system, and a clinical trials regulatory framework that facilitates rapid and efficient collaboration. Edge Trials has considerable experience in conducting first in human studies.
Pivotal trials for regulatory approval
The team at Edge Trials have experience in conducting trials for regulatory approval (European and FDA pathways). Our study procedures, including infrastructure, insure that clinical trial procedures are of sufficient standard to meet the rigors of external audit.

Why Work With Us
We are a dynamic, flexible, and highly experienced team.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.
Why Work With Us
We are a dynamic, flexible, and highly experienced team.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.

About Edge Trials
Edge Trials is led by Associate Professor Martin de Bock, and Dr Renee Meier.
Together they lead a wider team of research nurses, doctors, and research assistants. Positioned in a health and technology research precinct, in Canterbury New Zealand, they have strategic links with pharmacy, laboratory, radiology, and statistical support.




Questions? Answers!
Find quick answers to the most common questions we're being asked.
How long does it take from research concept to first patient first visit?
This depends on how complete and/or complex the study protocol. Typically from first contact to first patient first visit, is approximately 12 weeks.
How does Edge Trials differ from other research providers?
We have a unique set of skills – from being able to write protocols, set up electronic research databases, to statistical analyses. We can provide for short feasibility studies, to large scale multi-centre pivotal studies. We can cover the lifespan – with both paediatric and adult experience. Further, New Zealand is uniquely positioned, where regulatory processes for conducting first in human studies are efficient, and we can therefore accelerate research programs.
Do timezone differences from NZ cause issues?
The team at Edge are highly flexible. Having worked with international sponsors for over a decade, we’ve never encountered time-zone issues.
Is Edge Trials a CRO?
Edge Trials is not a CRO, however, we conduct all study procedures commonly performed by CROs. Reach out and find out what we can offer for your needs.
Would you conduct studies outside the diabetes technology space?
Discuss your study with us. We don’t conduct phase I and II studies, but are co-located within a research precinct that does, and can likely connect your needs with others if we can’t provide the service for your study needs. Our health expertise is within diabetes and endocrinology.
Questions? Answers!
Find quick answers to the most common questions we're being asked.
How long does it take from research concept to first patient first visit?
This depends on how complete and/or complex the study protocol. Typically from first contact to first patient first visit, is approximately 12 weeks.
How does Edge Trials differ from other research providers?
We have a unique set of skills – from being able to write protocols, set up electronic research databases, to statistical analyses. We can provide for short feasibility studies, to large scale multi-centre pivotal studies. We can cover the lifespan – with both paediatric and adult experience. Further, New Zealand is uniquely positioned, where regulatory processes for conducting first in human studies are efficient, and we can therefore accelerate research programs.
Do timezone differences from NZ cause issues?
The team at Edge are highly flexible. Having worked with international sponsors for over a decade, we’ve never encountered time-zone issues.
Is Edge Trials a CRO?
Edge Trials is not a CRO, however, we conduct all study procedures commonly performed by CROs. Reach out and find out what we can offer for your needs.
Would you conduct studies outside the diabetes technology space?
Discuss your study with us. We don’t conduct phase I and II studies, but are co-located within a research precinct that does, and can likely connect your needs with others if we can’t provide the service for your study needs. Our health expertise is within diabetes and endocrinology.
Questions? Answers!
Find quick answers to the most common questions we're being asked.
How long does it take from research concept to first patient first visit?
How does Edge Trials differ from other research providers?
We have a unique set of skills – from being able to write protocols, set up electronic research databases, to statistical analyses. We can provide for short feasibility studies, to large scale multi-centre pivotal studies. We can cover the lifespan – with both paediatric and adult experience. Further, New Zealand is uniquely positioned, where regulatory processes for conducting first in human studies are efficient, and we can therefore accelerate research programs.
Do timezone differences from NZ cause issues?
The team at Edge are highly flexible. Having worked with international sponsors for over a decade, we’ve never encountered time-zone issues.
Is Edge Trials a CRO?
Edge Trials is not a CRO, however, we conduct all study procedures commonly performed by CROs. Reach out and find out what we can offer for your needs.
Would you conduct studies outside the diabetes technology space?
Discuss your study with us. We don’t conduct phase I and II studies, but are co-located within a research precinct that does, and can likely connect your needs with others if we can’t provide the service for your study needs. Our health expertise is within diabetes and endocrinology.
Accelerate your diabetes trials with endocrine expertise
Helping companies bring innovative diabetes and endocrine therapies to market faster.
We specialise in diabetes technology clinical trials, combining scientific rigor with a fast, adaptive approach that keeps pace with rapidly evolving devices.


Years of combined industry experience
Years of combined industry experience
Feasibility and pivotal trials delivered
Feasibility and pivotal trials delivered
Global sponsors supported
Global sponsors supported
Training hours
Training hours
